Prime Medicine (PRME) Non Operating Income (2021 - 2026)

Prime Medicine (PRME) has 6 years of Non Operating Income data on file, last reported at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 205.18% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (up 242.68% YoY), and the FY2025 full-year result was $7.2 million, up 9.46% from the prior year.
• Non Operating Income for Q1 2026 stood at $1.5 million, down from $2.5 million in the prior quarter.
• Across five years, Non Operating Income topped out at $3.4 million in Q3 2025 and bottomed at -$7.2 million in Q4 2022.
• The 5-year median for Non Operating Income is $643000.0 (2023), against an average of $435588.2.
• The widest annual swing landed in 2022, when Non Operating Income soared 72900.0%; it then plunged 112.91% in 2024.
• A 5-year view of Non Operating Income shows it stood at -$7.2 million in 2022, then jumped by 48.54% to -$3.7 million in 2023, then soared by 152.51% to $1.9 million in 2024, then grew by 29.96% to $2.5 million in 2025, then tumbled by 39.42% to $1.5 million in 2026.
• The last three Non Operating Income figures came in at $1.5 million (Q1 2026), $2.5 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

Peer Comparison